Drug Makers React To Most-Favored Nation And IRA Pricing Policies
Direct Source Verification:
This story is aggregated from Forbes (forbes.com). Full reporting rights and copyright belong to the primary publisher.
The question becomes whether firms will respond by withdrawing drugs from certain markets or delaying launches of their newly approved drugs in these jurisdictions.
For complete coverage, context, and related multimedia, visit the original reporting by Forbes via the source link below.
Original Source
https://www.forbes.com/sites/joshuacohen/2026/10/01/drug-makers-react-to-most-favored-nation-and-ira-pricing-policies/
